Professor Hirohide Saito (Department of Life Science Frontiers at CiRA / The University of Tokyo) and Assistant Professor ...

Proteins are the infinitely varied chemicals that make cells work, and science has a pretty good idea how they are made. But ...

A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

To overcome the inherent challenge of translation termination interference caused by stop codon reprogramming in mammalian ...

Summary: New research reveals how a tiny chemical mark on RNA helps wire the brain during development. Scientists discovered ...

With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment of MaryJane Rafii, PhD, MBA, as Chief Investment and Business Officer.

Because they rely on hosts for a majority of functions, viruses aren’t considered alive. But entities like this one ...

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...